Nasdaq:TLRY
Tilray Brands, Inc.
A vertically integrated cannabis operator seeking to capitalize on global demand for legal marijuana products across multiple consumer channels.
Key Metrics
Investment Thesis
Bull Case
Long-term investors may view Tilray as a high-potential turnaround play in a sector projected to double in size over the next decade. The company's extensive retail network and premium brand portfolio position it well to capture market share once pricing pressures stabilize. If management can successfully pivot to profitability by optimizing its cost structure, the current valuation reflects significant downside protection against future recovery.
Bear Case
The recurring multi-billion dollar losses and negative operating cash flow indicate a fundamental business model that is currently unsustainable without external capital injections. The company's balance sheet shows a retained earnings deficit of $4.85B, highlighting how deeply entrenched the profitability issues are despite recent revenue increases. Investors should be wary of continued dilution through share issuances as the company attempts to fund its expansion and cover operational deficits.
About Tilray Brands, Inc.
Tilray Brands, Inc. is a leading Canadian producer of cannabis-based products operating primarily in North America, Europe, and Australia. The company leverages its vertically integrated supply chain to manufacture and distribute high-quality flower, concentrates, edibles, beverages, and accessories through a network of dispensaries and retail partners.
Analysis
Management Discussion
Despite a notable 31% year-over-year revenue growth to $821.3M in 2025, Tilray reported a substantial net loss of $2.18B, indicating that top-line expansion is not yet translating to profitability. The massive non-cash adjustments and operating expenses suggest significant write-downs or impairment charges, likely related to the company's large goodwill balance of $752.4M and ongoing market saturation struggles. Cash flow from operations turned negative at $94.6M, signaling that current growth strategies are burning through cash reserves rather than generating sustainable free cash flow.
Industry Overview
The global legal cannabis market is experiencing rapid maturation with increasing legalization trends in Europe, Asia, and North America creating a massive addressable opportunity. However, the industry is currently characterized by oversupply in flower categories and regulatory fragmentation that hampers cross-border commerce and standardization. Success will belong to operators who can achieve economies of scale while maintaining premium branding in a commodity-heavy market.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | $627.1M | $788.9M | $821.3M |
| Cost of Revenue | $480.2M | $565.6M | $580.7M |
| Gross Profit | $147.0M | $223.4M | $240.6M |
| Operating Expenses | $1.52B | $398.1M | $2.52B |
| Operating Income | $-1.37B | $-174.7M | $-2.28B |
| R&D | $682.0K | $635.0K | $284.0K |
| G&A | $165.2M | $167.4M | $167.3M |
| Stock-Based Comp | $39.6M | $31.8M | $24.3M |
| Other OpEx | $1.35B | $230.1M | $2.36B |
| Non-Operating Income | $-80.5M | $-74.3M | $-19.7M |
| Interest Expense | $46.6M | $49.3M | $41.3M |
| Interest Income | $33.0M | $12.8M | $11.4M |
| Pre-Tax Income | $-1.45B | $-249.0M | $-2.30B |
| Income Tax | $-7.2M | $-26.6M | $-121.0M |
| Continuing Ops | $-1.44B | $-222.4M | $-2.18B |
| Discontinued Ops | $0 | $0 | $0 |
| Net Income | $-1.44B | $-222.4M | $-2.18B |
| Minority Interest | $9.7M | $22.6M | $5.4M |
| Net to Common | $-1.45B | $-245.0M | $-2.19B |
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Current Assets | $773.0M | $677.7M | $688.6M |
| Cash & Equivalents | $206.6M | $228.3M | $221.7M |
| Marketable Securities | $241.9M | $32.2M | $34.7M |
| Accounts Receivable | $86.2M | $101.7M | $121.5M |
| Inventory | $200.6M | $252.1M | $270.9M |
| Prepaid Expenses | $37.7M | $31.3M | $34.1M |
| Other Current Assets | $0 | $32.1M | $5.8M |
| Long-Term Assets | $3.53B | $3.54B | $1.39B |
| PP&E (Net) | $429.7M | $558.2M | $568.4M |
| Intangibles | $973.8M | $915.5M | $21.4M |
| Goodwill | $2.01B | $2.01B | $752.4M |
| Operating Leases | $5.9M | $16.1M | $22.3M |
| LT Investments | $7.8M | $7.9M | $10.1M |
| Other LT Assets | $103.6M | $37.4M | $11.1M |
| Total Assets | $4.31B | $4.22B | $2.07B |
| Current Liabilities | $433.0M | $299.2M | $280.3M |
| Accounts Payable | $70.8M | $105.4M | $107.3M |
| Current Leases | — | $4.0M | $5.4M |
| Other Current Liab | $279.9M | $97.4M | $64.3M |
| Long-Term Liabilities | $544.3M | $479.3M | $304.4M |
| LT Operating Leases | — | $16.5M | $20.6M |
| Other LT Liab | — | $462.8M | $283.8M |
| Total Liabilities | $977.3M | $778.5M | $584.8M |
| Shareholders' Equity | $3.33B | $3.44B | $1.49B |
| Retained Earnings | $-2.42B | $-2.66B | $-4.85B |
| AOCI | $-46.6M | $-43.5M | $-43.1M |
| Total L&E | $4.31B | $4.22B | $2.07B |
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Net Income (CFO) | $-1.44B | $-222.4M | $-2.18B |
| Non-Cash Adjustments | $1.43B | $182.2M | $2.07B |
| Working Capital Changes | $25.7M | $9.3M | $16.7M |
| Cash from Operations | $7.9M | $-30.9M | $-94.6M |
| Cash from Investing | $-285.1M | $128.3M | $-46.7M |
| Cash from Financing | $70.2M | $-75.2M | $133.5M |
| FX Effect | $-2.2M | $-549.0K | $1.1M |
| Net Change in Cash | $-209.3M | $21.7M | $-6.7M |
| Beginning Cash | $415.9M | $206.6M | $228.3M |
| Ending Cash | $206.6M | $228.3M | $221.7M |
Frequently Asked Questions
How does Tilray Brands, Inc. make money?
The company's revenue is driven by its core Cannabis segment covering flower, concentrates, and extracts; an Edibles segment offering gummies, chocolates, and beverages; a Lifestyle Accessories segment selling vaping devices and paraphernalia; and international operations expanding into European and Australian markets.
What are the main risks for TLRY?
Regulatory uncertainty remains a paramount risk as the company operates in an evolving legal landscape where state and federal laws often conflict, particularly in the United States. The industry faces intense price competition leading to margin compression, especially in the flower segment where Tilray has seen significant operating losses. High inventory levels relative to revenue suggest potential obsolescence risks if demand slows or regulatory access contracts. Dependence on third-party dispensary relationships exposes the company to channel consolidation and distribution contract instability.
What is TLRY's competitive advantage?
Tilray benefits from a vertically integrated model controlling cultivation, extraction, and manufacturing which ensures quality consistency and cost control. The brand holds strong equity in premium lifestyle positioning with high-profile partnerships that differentiate it from generic competitors. Its diversified geographic footprint reduces reliance on any single regulatory environment while capturing growth in emerging international markets.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.